Affiliation:
1. Cooper Neurological Institute Cooper University Hospital Camden NJ
2. Cooper Medical School of Rowan University Camden NJ
3. Inspira Medical Center Mullica Hill NJ
4. Viz.ai San Francisco CA
5. Department of Neurology University of Chicago Chicago IL
Abstract
Background
Artificial intelligence platforms, like Viz.ai with large vessel occlusion detection, have been used for disease detection and interprovider communication. Whether this software expedites patient transfer and evaluation for treatment needs further exploration.
Methods
A single‐center retrospective registry was queried for patients with acute large vessel occlusion of the intracranial internal carotid, middle cerebral M1 or M2 segments, or basilar artery treated in a comprehensive stroke network (8 spokes, 1 hub) for 6 months pre‐ and post‐implementation of the Viz large vessel occlusion platform (excluding a 1‐month “washout” period). Robust regression was used to summarize time from initial hospital contact to arterial puncture (primary outcome) between periods, with prespecified subgroup analyses, which were assessed using interaction terms.
Results
Of the 132 patients (n = 58 preintervention), there were nonsignificantly fewer patients undergoing endovascular therapy in the postintervention period (86.2% preintervention versus 73.0% postintervention;
P
= 0.07). Among patients who underwent endovascular therapy (n = 50 preintervention, n = 54 postintervention), there was a nonsignificant reduction in time from first contact to arterial puncture (median 155 minute preintervention versus 116 minute postintervention;
P
= 0.10); however, this became significant in adjusted robust regression accounting for stroke severity, age, Alberta Stroke Program Early Computed Tomography Scale score, daytime versus nighttime and weekend versus weekday arrival, and use of perfusion imaging (β −20.9 [95% CI, −40.5 to −1.4)]. There was also a significant interaction observed for the association between spoke versus hub arrival and the Viz large vessel occlusion period, with shorter intervals observed for transferred patients (n = 32 preintervention with a median of 169 versus 142 minutes for n = 33 postintervention;
P
interaction
<0.01).
Conclusion
Implementation of the artificial intelligence platform was not associated with shorter intervals between initial hospital contact and neurointervention among all‐comers. A meaningful difference in time to treatment was observed among transferred patients. Larger data sets are needed to validate these observations.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference17 articles.
1. Endovascular therapy for ischemic stroke
2. Office of the Commissioner . FDA Permits Marketing of Clinical Decision Support Software for Alerting Providers of a Potential Stroke in Patients. U.S. Food and Drug Administration; 2020. [cited 2024 January, 15]. https://www.fda.gov/news‐events/press‐announcements/fda‐permits‐marketing‐clinical‐decision‐support‐software‐alerting‐providers‐potential‐stroke
3. FDA approves stroke‐detecting AI software;Nat Biotechnol,2018
4. The hub‐and‐spoke organization design revisited: a lifeline for rural hospitals;Elrod JK;BMC Health Serv Res,2017
5. Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献